| Browse by: | Sort by: |
Challenging Cases from Surgeons and Endocrinologists
A Dilemma of Neuroendocrine Proportion
TK Pandian, MD
Mayo Clinic, Rochester, MN
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
Refractory Cushing's Disease
Andrew J Swearingen, MD
Cleveland Clinic, Cleveland, OH
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
Primary Hyperparathyroidism: A New Diagnostic Pitfall
Kristina Nicholson, MD
University of Pittsburgh, Pittsburgh, PA
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
A Case of Rapidly Progressive Thyroid Carcinoma with Rare and Unexpected Pathology
Hunter J Underwood, MD
NYU Langone Medical Center, New York, NY
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
A 74 Year-old Male with Endocrinological Eye Exam
Alexander L Shifrin, MD
Jersey Shore University Medical Center, Neptune, NJ
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
High Pressure Decision Points
Philip W Smith, MD
University of Virginia, Charlottesville, VA
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
Embryological Symmetry As the Basis for Finding Missing Parathyroid Adenomas
Anton F Engelsman
Royal North Shore Hospital, University of Sydney, Sydney, Australia
Free
Slides + audio
Challenging Cases from Surgeons and Endocrinologists
Curious Case of Two Glands and a Zebra
Kathleen C Gallagher
Vanderbilt University Schood of Medicine, Nashville, TN
Free
Slides + audio
Nuclear Receptor Signaling: Master Regulator and Progeny
The Master Co-Regulator
Bert W O'Malley, M.D.
Baylor College of Medicine, Houston, TX
Permission not
granted for presentation
granted for presentation
Nuclear Receptor Signaling: Master Regulator and Progeny
Steroid Receptors in Endometrial Function
Milan K Bagchi, MS, PhD
University of Illinois at Urbana-Champaign, Urbana, IL
Available
Nuclear Receptor Signaling: Master Regulator and Progeny
Identification of targetable proteins and processes downstream of steroid receptors in breast and prostate cancers
Donald P McDonnell, PhD
Duke University School of Medicine, Durham, NC
Permission not
granted for presentation
granted for presentation
Adrenal Surgery: How Much is Too Much and How Little is Too Little?
Adrenal-Sparing Surgery or Total Adrenalectomy in MEN2 Pheochromocytoma
Frederic Castinetti, MD, PhD
Aix Marseille University - Assistance Publique Hopitaux de Marseille - La Conception Hospital, Marseille, France
Available
Adrenal Surgery: How Much is Too Much and How Little is Too Little?
Unilateral Adrenalectomy for Bilateral Adrenal Cushing's Syndrome
Antoine Tabarin, MD
University Hospital (CHU) of Bordeaux, Pessac, France
Available
Adrenal Surgery: How Much is Too Much and How Little is Too Little?
Surgical Approach to Adrenal Cortical Carcinoma: Past, Present, and Future
Jeffrey E Lee, MD
University of Texas, MD Anderson Cancer Center, Houston TX, TX
Available
Tumor Microenvironment in Hormonally Regulated Cancers
Adipose Derived Signals in Breast Cancer
Suzanne D Conzen, MD
University of Chicago, Chicago, IL
Available
Tumor Microenvironment in Hormonally Regulated Cancers
Cancer Associated Fibroblasts in the Breast TME and Circulation
Dorraya El-Ashry, PhD
University of Miami Miller School of Medicine, Miami, FL
Available
Tumor Microenvironment in Hormonally Regulated Cancers
Mammary Gland of Pregnancy: Microenviroment Effects on Cancer Progression
Pepper Schedin, PhD
Oregon Health Sciences University, Portland, OR
Available
Perioperative Management of Pituitary Tumors
Perioperative Management of Pituitary Tumors
Roberto Salvatori, MD
Johns Hopkins University, Baltimore, MD
Available
When Less is More in Low-Risk Thyroid Cancer Patients
When Less is More in Low-Risk Thyroid Cancer Patients
Gerard Doherty, MD
Brigham and Women's Hospital, Boston, MA
R Michael Tuttle, MD
Memorial Sloan Kettering Cancer Center, New York, NY
Available
Medullary Thyroid Cancer
Medullary Thyroid Cancer
Herbert Chen, MD
University of Alabama, Birmingham, AL
Maria E Cabanillas, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
Available
Chromatin Architecture and the Epigenome
Chromatin Remodeling and the Coordinate Control of Gene Expression
Trevor K Archer, BSC,PHD
Natl Inst Enviro Hlth Sci-NIH, Research Triangle Pk, NC
Available
Chromatin Architecture and the Epigenome
Enhancer RNA Regulation of AR Function in Prostate Cancer
Haojie Huang, Ph.D.
Mayo Clinic College of Medicine, Rochester, MN
Available
Chromatin Architecture and the Epigenome
Targeting Integrator in Cancer
Ramin Shiekhattar, Ph.D.
University of Miami, Miami, FL
Permission not
granted for presentation
granted for presentation
Controversy on Prolactin Action in Breast Cancer Progression
Chair
Vincent Goffin, PhD
Faculté de Médecine, Université Paris Descartes, Paris cedex 14, France
Available
Controversy on Prolactin Action in Breast Cancer Progression
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer
Neeraj Agarwal, MD
University of Utah, Salt Lake City, UT
Available
